The Beauty Health Company SKIN Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 64.9%-0.4pp | 65.3%+0.5pp | 64.8%+3.3pp | 61.5%+4.9pp | 56.6%+2.1pp | |
| Operating margin | -3.6%+3.3pp | -7%+2.3pp | -9.3%+4.7pp | -14%+5.5pp | -19.5%+0.8pp | |
| Net margin | -2%+1.1pp | -3.2%+0.7pp | -3.9%+2.2pp | -6.1%+5.8pp | -11.9%-3.2pp | |
| EBITDA margin | 3.1%+3.1pp | -0%+1.9pp | -1.9%+4.6pp | -6.5%+4.7pp | -11.2%+0.3pp | |
| Free cash flow margin | 9.6%-2.8pp | 12.4%-0.4pp | 12.8%— | —— | —— | |
| Returns | ||||||
| Return on equity | -12%+4.9pp | -16.9%+1.9pp | -18.7%+7.8pp | -26.5%+43.9pp | -70.4%-18.1pp | |
| Return on assets | -1.1%+0.6pp | -1.6%+0.3pp | -2%+1.2pp | -3.1%+2.0pp | -5.1%-1.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×+0.1× | 0.4×0.0× | |
| Inventory turnover | 1.8×+0.1× | 1.8×+0.1× | 1.6×-0.1× | 1.8×0.0× | 1.7×-0.2× | |
| Liquidity | ||||||
| Current ratio | 1.8×+0.1× | 1.7×-3.3× | 5×-0.2× | 5.1×-2.3× | 7.5×+0.5× | |
| Quick ratio | 1.5×+0.1× | 1.4×-2.7× | 4.1×-0.1× | 4.2×-2.3× | 6.4×+0.4× | |
| Cash ratio | 1.3×+0.1× | 1.2×-2.3× | 3.5×0.0× | 3.6×-2.4× | 5.9×+0.5× | |
| Leverage | ||||||
| Debt-to-equity | 2.3×0.0× | 2.3×-3.5× | 5.8×+0.7× | 5.1×+4.8× | 0.3×-10.6× | |
| Debt-to-assets | 0.3×0.0× | 0.3×-0.5× | 0.8×0.0× | 0.7×+0.7× | 0×-0.8× | |
| Net debt / EBITDA | -8.6×— | —— | —— | —— | —— | |
| Interest coverage | -0.5×+0.6× | -1.1×+0.7× | -1.8×+1.9× | -3.7×+2.6× | -6.4×+0.2× | |
| Per Share | ||||||
| Book value per share | $0.42-6.5% | $0.45-13.1% | $0.52-1.9% | $0.53+43.2% | $0.37+1.3% | |
| Valuation | ||||||
| Market capitalization | $89.75M-61.5% | $177.23M-29.8% | $252.38M+4.3% | $241.91M+44.1% | $167.83M-15.0% | |
| Enterprise value | $11.24M-96.2% | $82.88M-79.9% | $411.97M+1.3% | $406.64M+313% | -$190.5M-148% | |
| Price / sales | 0.3×-0.4× | 0.6×-0.2× | 0.8×+0.1× | 0.8×+0.3× | 0.5×-0.1× | |
| Price / book | 1.7×-1.6× | 2.9×-0.9× | 3.8×+0.6× | 3.3×-0.4× | 3.6×-0.2× | |
| EV / EBITDA | 1.7×— | —— | —— | —— | —— | |
| EV / sales | 0.1×-1.3× | 0.3×-1.1× | 1.4×+0.1× | 1.3×+1.9× | -0.6×-1.8× | |
| Free cash flow yield | 30.2%— | 21%+5.7pp | 15.3%— | —— | —— | |
| Earnings yield | -6.4%+1.3pp | -5.4%-0.7pp | -4.7%+3.2pp | -7.9%+15.1pp | -22.9%-8.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are The Beauty Health Company's profit margins?
- The Beauty Health Company (SKIN) runs a 64.9% gross margin and a -3.6% operating margin, with a -2.0% net margin.
- Where do The Beauty Health Company's ratios come from?
- Every ratio is computed from The Beauty Health Company's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
